Voting Himself Rich: CDC Vaccine Adviser Made $29 Million Or More After Using Role to Create Market ageofautism.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ageofautism.com Daily Mail and Mail on Sunday newspapers.
By Mark Blaxill “Cash in: To withdraw from a venture by or as if by settling one’s account.” Paul Offit would like the world to see him as a champion of children’s health and a disinterested observer of controversial issues.
ME s Note: We ran this post ten days ago. Seemed valuable to share it again. By Mark Blaxill Vaccine developer Paul Offit has just published a new book, Deadly Choices, in which he turns up the volume and the rhetoric.
By Dan Olmsted and Mark Blaxill Paul Offit, vaccine entrepreneur and public health spokesperson, has earned approximately $10 million in income from Rotateq® royalties through 2009 and stands to earn a total of between $13-35 million over the life of.
PHILADELPHIA – A federal appellate court has unanimously determined that arbitration proceedings are forthcoming for a class-action lawsuit filed against Merck, which alleged that the pharmaceutical giant discouraged competition for its rotavirus vaccine.